NCT04021563View on ClinicalTrials.gov

The Safety, Tolerability, Pharmacokinetics(PK) of SR419 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

SR419

Ascending single and multiple doses of SR419 orally

DRUG

Placebo

Ascending single and multiple doses of placebo orally

Trial Locations (1)

Unknown

Linear Clinical Research, Perth

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Syneos Health

OTHER

lead

Shanghai SIMR Biotechnology Co., Ltd.

INDUSTRY